Injecting drug users and antiretroviral therapy: Perceptions of pharmacy teams

Revista de Saude Publica

Volumn 41, Issue SUPPL. 2, 2007, Pages 14-21

  Yokaichiya, Chizuru Minami ^a   Figueiredo, Wagner dos Santos ^b   Schraiber, Lilia Blima ^b  

^a Secretaria Municipal de Saude de Sao Paulo   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acquired immunodeficiency syndrome, drug therapy; Anti HIV agents, supply distribution; Anti retroviral agents, supply distribution; Health knowledge, attitudes, practice; Patient care team, ethics; Pharmaceutical services, ethics; Substance abuse, intravenous

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; ATTITUDE TO HEALTH; HEALTH PERSONNEL ATTITUDE; HOSPITAL PHARMACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RELATION; INFORMATION PROCESSING; MIDDLE AGED; PATIENT CARE; PATIENT COMPLIANCE; PERCEPTION; PHARMACIST; PROFESSIONAL STANDARD; PSYCHOLOGICAL ASPECT; STANDARD; SUBSTANCE ABUSE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; ATTITUDE OF HEALTH PERSONNEL; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MIDDLE AGED; PATIENT CARE TEAM; PATIENT COMPLIANCE; PERCEPTION; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE; PROFESSIONAL-PATIENT RELATIONS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 38049166049     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-89102007000900005     Document Type: Article

References (17)

1. Bultman DC, Svarstad BL. Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy. J Am Pharm Assoc (Wash) [periódico na internet].2002 [acesso 09 ago 2004];42(1):36-43. Disponível em: http://www.medscape.com/ viewarticle/436594
2. Cantwell-Mcnelis K, James CW. Role of Clinical Pharmacists in Outpatient HIV Clinics. Am J Health Syst Pharm [periódico na internet].2002 [acesso em 18 mar 2006];59(5):447-52. Disponível em: http://www.medscape.com/viewarticlet429911_print
3. Carlini-Cotrim B. Potencialidades da tcecnica qualitativa grupo focal em investigações sobre abuso de substâncias. Rev Saude Publica. 1996;30(3):285-93.
4. Celentano DD, Galai N, Sethi AK, Shah NG, Strathdee SA, Vlahov D, et al. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS [periódico na internet].2001 [acesso 16 mar 2006];15(13):1707-15. Disponível em: http://www.aidsonline.com/pt/re/aids/fullte)ct.00002030-200109070- 00015.htm;jsessionid=Edel1TyYVb6BhmYjrjIY47qkWqDzZUXWV1tPW8jguoY VwRXuWFMO!-1070481199!-949856145!9001!-1
5. Dray-Spira R, Lert F. Social health inequalities during the course of chronic HIV disease in the era of highly active antiretroviral therapy. AIDS [periódico na internet]. 2003 [acesso ern 16 mar 2006];17(3):283-90. Disponível em: http://www.aidsonline.com/pt/ re/aids/fulltext.00002030-200302140-OOOOI.htm;jsessionid= EdfaBbCA3d4tGa6CogLXEXghcbTzJYC2YafISdN2EXc7bDOoQASr!-l070481199!- 949856145!9001!-l
6. Goffman E. Estigma: Notas sobre a manipulação de uma identidade deteriorada. 4.ed. Rio de Janeiro; LTC; 1988.
7. Hepler CD, Strand LM. Oportunidades y responsabilidades en la Atención Farmacéutica. Pharm Care Esp. 1999; 1(1):35-47.
8. Krueger RA. Focus Groups. A practical Guide for Applied Research. Thousand Oaks: Sage Publications; 1994.
9. Malta M, Petersen ML, Clair S, Freitas F, Bastos Fl. Adherence to antiretroviral therapy: a qualitative study with physicians from Rio de Janeiro, Brazil. Cad Saude Publica. 2005;21(5):1424-32.
10. Marin N, Osório-de-Castro CGS, Machado-dos-Santos S. organizadctres. Assistência farmacêutica para gerentes municipais. Rio de Janeiro: Organização Pan Americana de Saúde/Organização Mundial da Saúde; 2003.
11. Minayo MCS. O desafio do conhecimento: pesquisa qualitativa em saúde. 7.ed. São Paulo: Hucitec; 2000.
12. Organizaç⊤iao Pan Americana de Saúde/ Organização Mundial da Saúde. Consenso Brasileiro de Atenção Farmacêutica: proposta. Atenção Farmacêutica no Brasil: "Trilhando Caminhos". Brasília; 2002.
13. Parker R, Aggleton P. Estigma, Discriminação e AIDS. Rio de Janeiro: Associação Brasileira Initerdisciplinar em AIDS; 2001. [Coleção ABIA: Cidadania e Direitos, 1].
14. Schiller DS. Identification, management, and prevention of adverse effects associated with highly active anti retroviral therapy. Am J Health Syst Pharm [periódico na internet].2004 lacesso 16 mar 2006];61(23):2507-2522. Disponível em: http://www.medscape.com/ viewarticle/497920∥int
15. Schraiber LB. Violência contra as mulheres e políticas de saúde no Brasil: o que podem fazer os serviços de saúde? Rev USP 2001;(51):104-13.
16. Wood E, Montaner JS, Bangsberg DR, Tyndall MW, Strathdee SA, O'Shaughnessy MV et al. Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world. AIDS [periódico na internet].2003 [acesso em:18 mar 2006]; 17(17):2419-27. Disponível em: http://www.aidsonline.com/pt/ relaids/fulltext.00002030-200311210-00003.htm;jsessionid= EdlsaelSIREgdSheeWzEK9SCk5PsLCIVHBwlgMOVyM6h930sgvrr!-1070481199!- 949856145!9001!-1
17. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva; 2003.